The use of cardiac hormones for diagnosing the risk of...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/74 (2006.01)

Patent

CA 2567738

The present invention relates to the use of cardiac hormones, particularly natriuretic peptides, for diagnosing the risk of suffering from a cardiovascular complication, particularly heart disease or acute coronary syndrome, as a consequence of cardiotoxic medication, in particular chemotherapeutics, including anthracyclines. In particular, the invention relates to a method for diagnosing the risk of a patient who is going to receive cardiotoxic medication of suffering from a cardiovascular complication as a consequence of the cardiotoxic medication, comprising the steps of (a) taking a body fluid or tissue sample, and (b) measuring, preferably in vitro, the level of a cardiac hormone. Preferred cardiac hormones in the context of the present invention are ANP, NT-proANP, BNP, and NT-proBNP.

La présente invention concerne l'utilisation d'hormones cardiaques, et plus particulièrement de peptides natriurétiques, pour le diagnostic des risques de complications cardiovasculaires, et plus précisément d'une maladie du coeur particulière ou d'un syndrome coronarien aigu, dues à une intoxication liée à un médicament cardiotoxique, en particulier un agent chimiothérapeutique, y compris des anthracyclines. L'invention concerne plus particulièrement une méthode destinée au diagnostic des risques de complications cardiovasculaires dues à une intoxication liée à un médicament cardiotoxique. Cette méthode consiste (a) à prélever un liquide ou un tissu organique et (b) à mesurer, de préférence in vitro, la concentration d'hormone cardiaque. Les hormones cardiaques préférées dans le contexte de la présente invention sont les suivantes : ANP, NT-proANP, BNP, et NT-proBNP.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

The use of cardiac hormones for diagnosing the risk of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with The use of cardiac hormones for diagnosing the risk of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of cardiac hormones for diagnosing the risk of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1623472

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.